RE: Another blue31 Jul 2018 15:04
Note from the company on 14th June 2018
ImmuPharma, the specialist drug discovery and development company, revealed Thursday its Lupus drug showed positive signs of treating other autoimmune diseases in addition to Lupus.
The findings of a pre-clinical study of ImmuPharma's lupus drug, P140/Lupuzor, for chronic inflammatory demyelinating polyneuropathy, or CIPD, - an autoimmune-mediated inflammatory disease - improved the clinical and biological course of the disease, the company said.
'We are delighted that these results demonstrate positive pre-clinical data in a murine model of CIDP, which has no available disease-specific treatment. We look forward to providing a further update on the progress of our CIDP programme in due course,' Professor Sylviane Muller said.